We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.48%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.5B
AUM Growth
+$1.76B
(+5.4%)
Cap. Flow
-$769M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.77%
Holding
1,963
New
176
Increased
1,051
Reduced
620
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$68.7M |
| 2 |
GE HealthCare
GEHC
|
+$28.6M |
| 3 |
ON Semiconductor
ON
|
+$28.1M |
| 4 |
Caterpillar
CAT
|
+$22.6M |
| 5 |
IBM
IBM
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$94.9M |
| 2 |
Apple
AAPL
|
+$91M |
| 3 |
West Pharmaceutical
WST
|
+$69M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$61.8M |
| 5 |
Amazon
AMZN
|
+$55.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Industrials | 12.05% |
| 3 | Consumer Staples | 10.74% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Generac Holdings
GNRC
$11.9B
| $1.67M | ﹤0.01% |
11,172
-2,476
| -18% | -$282K |
|
677
Allegion
ALLE
$13B
| $1.6M | ﹤0.01% |
13,320
+414
| +3% | +$45.2K |
|
|
MMP
678
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $1.57M | ﹤0.01% |
25,167
+5,721
| +29% | +$334K |
|
679
Zions Bancorporation
ZION
$10.1B
| $1.54M | ﹤0.01% |
57,477
-3,891
| -6% | -$108K |
|
680
Alnylam Pharmaceuticals
ALNY
$36.3B
| $1.53M | ﹤0.01% |
8,057
-757
| -9% | -$150K |
|
681
Robert Half
RHI
$3.61B
| $1.52M | ﹤0.01% |
20,173
-196
| -1% | -$14K |
|
|
ROVR
682
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $1.49M | ﹤0.01% |
303,118
+86,300
| +40% | +$395K |
|
683
NRG Energy
NRG
$29.8B
| $1.48M | ﹤0.01% |
39,534
-34,117
| -46% | -$1.16M |
|
|
ISEE
684
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.42M | ﹤0.01% |
35,988
+10,481
| +41% | +$370K |
|
685
Norwegian Cruise Line
NCLH
$8.89B
| $1.39M | ﹤0.01% |
63,925
+2,488
| +4% | +$38.1K |
|
686
Dentsply Sirona
XRAY
$2.59B
| $1.35M | ﹤0.01% |
33,771
+609
| +2% | +$24.2K |
|
687
Entegris
ENTG
$19.7B
| $1.34M | ﹤0.01% |
12,121
+1,443
| +14% | +$132K |
|
|
PETQ
688
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.34M | ﹤0.01% |
88,080
+23,439
| +36% | +$301K |
|
689
Silicon Laboratories
SLAB
$7.15B
| $1.32M | ﹤0.01% |
8,397
+568
| +7% | +$85.8K |
|
690
Bath & Body Works
BBWI
$4.01B
| $1.29M | ﹤0.01% |
34,485
-9,600
| -22% | -$351K |
|
691
Bio-Rad Laboratories Class A
BIO
$8.42B
| $1.28M | ﹤0.01% |
3,383
-19
| -0.6% | -$7.73K |
|
692
United Therapeutics
UTHR
$26.3B
| $1.27M | ﹤0.01% |
5,769
-152
| -3% | -$33.7K |
|
693
Hasbro
HAS
$12.6B
| $1.27M | ﹤0.01% |
19,628
+740
| +4% | +$43.2K |
|
|
GTLS
694
DELISTED
Chart Industries
GTLS
| $1.27M | ﹤0.01% |
7,945
+390
| +5% | +$49.8K |
|
|
CTLT
695
DELISTED
CATALENT, INC.
CTLT
| $1.25M | ﹤0.01% |
28,853
+490
| +2% | +$21.5K |
|
696
Novanta
NOVT
$5.04B
| $1.24M | ﹤0.01% |
6,752
+447
| +7% | +$73.1K |
|
697
Halozyme
HALO
$9.72B
| $1.21M | ﹤0.01% |
33,581
+477
| +1% | +$16.3K |
|
698
Chord Energy
CHRD
$7.79B
| $1.21M | ﹤0.01% |
7,874
+508
| +7% | +$73.7K |
|
|
PARA
699
DELISTED
Paramount Global Class B
PARA
| $1.19M | ﹤0.01% |
74,851
+2,330
| +3% | +$42.1K |
|
700
MPLX
MPLX
$59.5B
| $1.18M | ﹤0.01% |
34,879
+608
| +2% | +$20.8K |
|
Similar funds
ProShare Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, ProShare Advisors held 1,963 positions worth $34.5B, up 5.4% from $32.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
ProShare Advisors's Q2 2023 filing shows 176 new, 1,051 increased, 620 reduced and 112 closed positions. Its largest new stake was Artesian Resources: 162,581 shares worth $7.68M. The largest sale was Microsoft, an estimated $94.9M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q2 2023 buy was Artesian Resources: 162,581 shares worth $7.68M.
- ProShare Advisors added most to Albemarle in Q2 2023, an estimated $68.7M increase.
- ProShare Advisors's biggest Q2 2023 reduction was Microsoft, cutting an estimated $94.9M.
- ProShare Advisors fully exited Rivian in Q2 2023, selling an estimated $11.9M.
- ProShare Advisors's ten largest holdings make up 27% of its $34.5B portfolio in Q2 2023.
- ProShare Advisors opened 176 new positions and closed 112 in Q2 2023.
- ProShare Advisors's portfolio value rose 5.4% quarter-over-quarter to $34.5B.
Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.